Back to results
US 2025/0059540 A1Published application
Double stranded rna targeting angiopoietin-like 3 (angptl-3) and methods of use thereof
AssigneeSanegene Bio USA Inc.
InventorsChunyang ZHANG, Shiyu WANG, Xiaochuan CAI, Weimin WANG, Zhongfa YANG
Life of this patent
Estimating the term…
Abstract
The disclosure relates to isolated oligonucleotides comprising duplex regions targeting angiopoietin-like 3 (ANGPTL-3), and delivery systems, kits and compositions comprising same, and methods of using same for inhibiting or downregulating ANGPTL-3.
Claims2
An isolated oligonucleotide comprising a sense strand and an anti-sense strand, wherein:
- the sense strand comprises a nucleotide sequence that is substantially identical to a region comprising 19-25 nucleotides between any one of the nucleotide positions selected from:
- a) 52 to 93;
- b) 133 to 184;
- c) 246 to 304;
- d) 337 to 414;
- e) 433 to 503;
- f) 522 to 571;
- g) 617 to 700;
- h) 717 to 737;
- i) 836 to 905;
- j) 944 to 964;
- k) 1013 to 1093;
- l) 1353 to 1386;
- and
- m) 1407 to 1427,
- from the 5′ end of an Angiopoietin-like protein 3 (ANGPTL-3) mRNA sequence according to SEQ ID NO:
- 1,
- and the anti-sense strand is substantially complementary to the sense strand such that the sense strand and the anti-sense strand together form a double stranded region.
15 more elements
-51. (canceled)
Dependencies are inferred from the claim text.